Stocks are steady ahead of the Fed

Stock markets are creeping higher this morning as traders will be focused on the Fed meeting tonight.

Federal Reserve building
Source: Bloomberg

The overnight session in Asia was mixed and the volatility was low as investors in the Far East were in wait and see mode. The mood in Europe is slightly more optimistic but trading volumes and market volatility are expected to be low in the run up to the Federal Reserve meeting. Traders who are active today seem to be happy to take on more risk, as Rio Tinto and Glencore are performing well, while defensive plays like GlaxoSmithKline and Shire are in the red. This bodes well for the equity rally that started just over a month ago.

The Fed fund futures market is pricing in a 4% probability of a rate hike tonight, so the focus will be on the commentary. Investors will try and ascertain whether the Fed will continue down the path of gradual rate hikes or else take a breather. A lot has changed since early 2016, and the jump in the price of oil and the declining fear surrounding China may make Janet Yellen more optimistic in her outlook. Should the Fed sound more hawkish, it will encourage equity traders to remain long and stocks are still relatively cheap compared with the beginning of the year. On paper, dovish commentary would be a sign to buy, but if the US central bank sounds concerned about the global economy it could trigger a wave of selling. 

The UK budget could have an impact on a number of sectors. Insurers like Aviva and Legal & General are in positive territory at the moment, but Mr. Osborne is tipped to make changes to the pensions industry which could impact the way they do business. The pub sector is expected to be assisted by the reduction in the tax on alcohol, which would be of assistance to Mitchells & Butlers, and JD Wetherspoon

FTSE risers and fallers (as of 9.30am)

Company % change Index points
BP +2.25 +5.47
Royal Dutch Shell A +1.72 +4.67
Royal Dutch Shell B +1.93 +4.67
HSBC Holdings +0.55 +1.9
Rio Tinto +1.74 +1.6

 

Company % change Index points
GlaxoSmithKline -1.48 -3.98
Shire -4.3 -3.71
AstraZeneca -1.33 -2.63
TUI AG -5.45 -1.04
BT Group -0.51 -0.75

The day ahead

Economic data:

12.30pm – UK budget: chancellor George Osborne will unveil fresh budget measures for the UK economy.

12.30pm – US CPI (February): US price growth expected to be 1.3%, down from 1.4%, while core prices rise 2.1%, down from 2.2%.

3.30pm – EIA crude inventories: forecast to rise by 1.5 million barrels, lower than previous week’s 3.8 million increase. Gasoline stockpiles forecast to fall by 1.9 million barrels, from the notable from of over 4 million a week earlier.

6pm – Fed meeting: no change to policy expected, with rates likely to remain at current levels. However, commentary may well indicate whether the FOMC is still looking to carry on with gradual tightening.

Corporate earnings:

US: FedEx Corp

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.